SCHEMBL8154689

SCHEMBL8154689

CCCCC1NC(=O)CN(Cc2ccccc2)C1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 5/20 0.55
HDAC6 Q9UBN7 5/20 0.54
HDAC1 Q13547 4/20 0.54
HDAC8 Q9BY41 4/20 0.54
KMT2A Q03164 3/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
EPHX2 P34913 1/20 0.44
GHSR Q92847 3/20 0.42
HDAC4 P56524 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
SIRT5 Q9NXA8 1/20 0.41
GAA P10253 1/20 0.41
TACR1 P25103 1/20 0.41
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10219033 1.00 OPRK1 (0.55) OPRK1HDAC6HDAC1HDAC8KMT2A
SCHEMBL8447778 1.00 OPRK1 (0.55) OPRK1HDAC6HDAC1HDAC8KMT2A
SCHEMBL1714131 0.92 OPRK1 (0.57) OPRK1HDAC6HDAC1HDAC8KMT2A
SCHEMBL10219026 0.92 OPRK1 (0.57) OPRK1HDAC6HDAC1HDAC8KMT2A
SCHEMBL19095468 0.92 OPRK1 (0.57) OPRK1HDAC6HDAC1HDAC8KMT2A
SCHEMBL873191 0.88 HDAC6 (0.55) OPRK1HDAC6HDAC1HDAC8ALDH1A1
SCHEMBL873192 0.88 HDAC6 (0.55) OPRK1HDAC6HDAC1HDAC8ALDH1A1
SCHEMBL334581 0.86 OPRK1 (0.59) OPRK1HDAC6HDAC1HDAC8EPHX2
SCHEMBL1714279 0.86 OPRK1 (0.59) OPRK1HDAC6HDAC1HDAC8EPHX2
SCHEMBL6343378 0.86 OPRK1 (0.59) OPRK1HDAC6HDAC1HDAC8EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6030946-A FUNCTIONS REVERSIBLY, RESULTING IN TIGHT BINDING (LOW DISSOCIATION CONSTANTS) BETWEEN INHIBITOR AND TARGET ENZYME; USED TO TREAT VARIETY OF DISEAES, INCLUDING ARTHRITIS, MUSCULAR DYSTROPHY, INFLAMMATION, TUMOR INVASION, MALERIA AXYS PHARMACEUTICALS, INC. (US) 2000-02-29 US disclosed
US-5856326-A ANTITUMOR, ANTICANCER AGENTS MERCK & CO., INC. (US) 1999-01-05 US disclosed
US-5736539-A ANITCARCINOGENIC AGENTS MERCK & CO., INC. (US) 1998-04-07 US disclosed
EP-0832099-A1 REVERSIBLE CYSTEINE PROTEASE INHIBITORS ARRIS PHARMACEUTICAL CORPORATION (US) 1998-04-01 EP disclosed
EP-0820445-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE Merck & Co., Inc. (US) 1998-01-28 EP disclosed
WO-1996040737-A1 REVERSIBLE CYSTEINE PROTEASE INHIBITORS ARRIS PHARMACEUTICAL CORPORATION (US) 1996-12-19 WO disclosed
WO-1996030343-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1996-10-03 WO disclosed
EP-0703905-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO. INC. (US) 1996-04-03 EP disclosed
WO-1995000497-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1995-01-05 WO disclosed